LAMAKAMA LTD

Lamakama Ltd, operating under the brand KamaLama, is a health technology company that provides AI-driven health risk assessments focused on longevity factors.

Reviewed by 7wData
Share Email

On this page

Profile

Provides an online health assessment tool that estimates life expectancy and biological age based on 30 scientifically validated factors.

Lamakama Ltd, operating under the brand KamaLama, is a health technology company that provides AI-driven health risk assessments focused on longevity factors. The company's platform analyzes 30 scientifically validated factors that impact lifespan, offering users personalized insights into their biological age, life expectancy, and health risks. KamaLama's methodology is based on a review of 7.6 million research studies, filtered down to 600 high-confidence papers, to identify the most significant evidence-based predictors of longevity.

The platform requires no sign-up and stores all data locally on the user's device, emphasizing privacy. While the company's founding details and headquarters location are not publicly disclosed, its product has gained traction for its science-backed approach to health assessment. KamaLama does not currently disclose funding rounds, revenue, or headcount, but its free-to-use model suggests a focus on user adoption before monetization.

The company's whitepaper outlines its rigorous research methodology, which may appeal to health-conscious consumers and researchers alike. What's interesting now is the growing consumer interest in longevity science and personalized health metrics, positioning KamaLama in a competitive but expanding market.

Track LAMAKAMA LTD and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Health-conscious individuals seeking personalized longevity insights
  • Researchers and academics interested in evidence-based health factors
  • Corporate wellness programs looking for employee health assessment tools
  • Healthcare providers needing supplemental patient risk assessment tools

Strengths and what to watch

Strengths

  • Science-backed methodology validated across 7.6 million research studies
  • Privacy-focused approach with all data stored locally on user devices
  • Clear focus on 30 high-impact factors distilled from extensive research

Watch for

  • Lack of disclosed revenue model or monetization strategy
  • No public information about company leadership or founding team
  • Potential challenges in validating AI models against individual health outcomes

Key Information

Founded
2025

Frequently Asked Questions

What is Lamakama Ltd?

Lamakama Ltd is a health technology company operating under the brand KamaLama. It provides an AI-driven health assessment tool that estimates life expectancy and biological age based on 30 scientifically validated factors, offering personalized insights into health risks and longevity.

How does KamaLama assess health risks?

KamaLama analyzes 30 scientifically validated factors impacting lifespan, derived from a review of 7.6 million research studies. The platform uses AI to provide personalized insights into biological age, life expectancy, and health risks, focusing on evidence-based predictors of longevity.

Is KamaLama's health assessment tool private?

Yes, KamaLama emphasizes privacy by storing all user data locally on their devices. The platform requires no sign-up, ensuring that personal health information remains secure and accessible only to the user, aligning with privacy-focused health technology practices.

Who uses KamaLama's health assessment tool?

KamaLama serves health-conscious individuals, researchers, corporate wellness programs, and healthcare providers. Its tool offers personalized longevity insights, evidence-based health factors, and supplemental risk assessments, catering to diverse customer segments interested in science-backed health metrics.

What makes KamaLama's methodology reliable?

KamaLama's methodology is based on a review of 7.6 million research studies, filtered to 600 high-confidence papers. This rigorous process identifies 30 scientifically validated factors impacting longevity, ensuring the platform's insights are evidence-based and reliable for health assessment.

Does KamaLama disclose its revenue model?

KamaLama does not currently disclose its revenue model or monetization strategy. The platform operates as a free-to-use tool, suggesting a focus on user adoption and engagement before exploring potential monetization avenues in the future.

Sources

  1. www.kamalama.org — Company product offering and methodology
  2. www.kamalama.org — Research methodology and scientific validation claims
  3. www.kamalama.org — Example of factor analysis in the platform
  4. www.kamalama.org — Specific longevity factor implementation